Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

50 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Off Treatment Notice Revised - 2169415v3.0 - CALGB: 90104 Off Treatment Notice Revised

- 09/01/2015 - 1 Formulaire, 1 Groupe Item, 20 Eléments de données, 1 Langue
Groupe Item: CCRR MODULE
CALGB: 90104 Off Treatment Notice Revised Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B4CED-A464-70DB-E034-0003BA12F5E7

E5508 Off-Treatment Form NCT01107626 - E5508 Off-Treatment Form NCT01107626

- 16/06/2015 - 1 Formulaire, 7 Groupes Item, 23 Eléments de données, 1 Langue
Groupes Item: Header Module, Patient demographics, Data amendment, Vital Status, Section I, Section II, Comments
E5508 Off-Treatment Form NCT01107626 Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D41D0A3-B031-13D4-E040-BB89AD430599

E1208 Off-Treatment Form NCT01004978

- 16/06/2015 - 1 Formulaire, 8 Groupes Item, 26 Eléments de données, 1 Langue
Groupes Item: Header Module, Patient demographics, Data amendment, Vital Status, Protocol therapy, Off-protocol treatment, Section II, Comments
E1208 Off-Treatment Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7041BC2E-D506-911B-E040-BB89AD432643

North Central Cancer Treatment Group N0723 End Of Active Treatment/Cancel Notification Form NCT00738881

- 08/06/2015 - 1 Formulaire, 2 Groupes Item, 16 Eléments de données, 1 Langue
Groupes Item: Header Module, Preregistration Screening Failure
North Central Cancer Treatment Group N0723 End Of Active Treatment/Cancel Notification Form NCT00738881 Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46AC6BB1-F9DF-4B4C-E044-0003BA3F9857

Lung Cancer NCT00049543 Off Treatment - Off Treatment Form - 2034390v3.0 - Off Treatment Form

- 09/01/2015 - 1 Formulaire, 9 Groupes Item, 36 Eléments de données, 1 Langue
Groupes Item: 1. PATIENT INFORMATION, 2. OFF PROTOCOL THERAPY, NCIC CTG use only2, NCIC CTG use only, Header, 3. UNBLINDING, 4. COMMENTS, 5. INVESTIGATOR SIGNATURE, CCRR MODULE
Off Treatment Form Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A069F1F1-C7BA-50DA-E034-080020C9C0E0

Lung Cancer NCT00049543 Off Treatment - Emergency Unblinding Form - 2279706v3.0 - Emergency Unblinding Form

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: 1. Patient Information, 2. Unblinding Information, 3. Signature
Emergency Unblinding Form Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D98AA788-C380-49AB-E034-0003BA12F5E7

Lung Cancer NCT01336894 Off Treatment - ACOSOG-Z4099 End of Intervention Form - 3178441v1.0 - ACOSOG-Z4099 End of Intervention Form

- 09/01/2015 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Header Module, Off-Treatment Reason
ACOSOG-Z4099 End of Intervention Form Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9869A599-BCAB-139E-E040-BB89AD432862

Lung Cancer NCT00107172 Off Treatment - Z4032 End of Intervention Period - 2306382v3.0 - Z4032 End of Intervention Period

- 08/01/2015 - 1 Formulaire, 3 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Header Module, Header, Footer Module
Z4032 End of Intervention Period Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F20E8F7F-CB09-6BD0-E034-0003BA3F9857

Off-Treatment Form Lung Cancer (NCT00324805)

- 07/01/2015 - 1 Formulaire, 3 Groupes Item, 24 Eléments de données, 1 Langue
Groupes Item: Header, Vital Status, Treatment
ECOG-E1505 Off-Treatment Form Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery NCT00324805 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=07459D41-1B93-4F16-E044-0003BA3F9857

Off-Treatment Form Kidney Cancer (NCT00326898)

- 07/01/2015 - 1 Formulaire, 3 Groupes Item, 24 Eléments de données, 1 Langue
Groupes Item: Header, Vital Status, Treatment
E2805 Off-Treatment Form Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery NCT00326898 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=054AD4FB-BA76-2822-E044-0003BA3F9857

S0205 Off Treatment Notice NCT00075686

- 03/07/2015 - 1 Formulaire, 4 Groupes Item, 25 Eléments de données, 1 Langue
Groupes Item: SWOG clinical trial administrative data, Reporting period, Notes, CCRR MODULE
S0205 Off Treatment Notice NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A11E1F7E-5275-2148-E034-080020C9C0E0

CALGB: OFF TREATMENT NOTICE [80303] NCT00088894

- 03/06/2015 - 1 Formulaire, 4 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Off protocol treatment, Comments
CALGB: OFF TREATMENT NOTICE [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D5FECAA1-76F0-6E26-E034-0003BA12F5E7

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial